These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23374856)

  • 1. Lung CD8+ T cells in COPD have increased expression of bacterial TLRs.
    Freeman CM; Martinez FJ; Han MK; Washko GR; McCubbrey AL; Chensue SW; Arenberg DA; Meldrum CA; McCloskey L; Curtis JL
    Respir Res; 2013 Feb; 14(1):13. PubMed ID: 23374856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
    Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
    J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis.
    Mansson A; Adner M; Cardell LO
    Respir Res; 2006 Feb; 7(1):36. PubMed ID: 16504163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease.
    Nadigel J; Préfontaine D; Baglole CJ; Maltais F; Bourbeau J; Eidelman DH; Hamid Q
    Respir Res; 2011 Nov; 12(1):149. PubMed ID: 22070100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD.
    Ji J; von Schéele I; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1035-43. PubMed ID: 27274225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease.
    Barczyk A; Pierzchała W; Kon OM; Cosio B; Adcock IM; Barnes PJ
    J Allergy Clin Immunol; 2006 Jun; 117(6):1484-92. PubMed ID: 16751017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.
    Freeman CM; Han MK; Martinez FJ; Murray S; Liu LX; Chensue SW; Polak TJ; Sonstein J; Todt JC; Ames TM; Arenberg DA; Meldrum CA; Getty C; McCloskey L; Curtis JL
    J Immunol; 2010 Jun; 184(11):6504-13. PubMed ID: 20427767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of toll-like receptors on CD14+ monocytes from patients with chronic obstructive pulmonary disease and smokers].
    Pan MM; Sun TY; Zhang HS
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2103-7. PubMed ID: 19080469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease.
    Hodge G; Mukaro V; Reynolds PN; Hodge S
    Clin Exp Immunol; 2011 Oct; 166(1):94-102. PubMed ID: 21910726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages.
    Lea SR; Reynolds SL; Kaur M; Simpson KD; Hall SR; Hessel EM; Singh D
    Int J Chron Obstruct Pulmon Dis; 2018; 13():771-780. PubMed ID: 29535517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered effector function of peripheral cytotoxic cells in COPD.
    Urbanowicz RA; Lamb JR; Todd I; Corne JM; Fairclough LC
    Respir Res; 2009 Jun; 10(1):53. PubMed ID: 19545425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease.
    Freeman CM; Stolberg VR; Crudgington S; Martinez FJ; Han MK; Chensue SW; Arenberg DA; Meldrum CA; McCloskey L; Curtis JL
    PLoS One; 2014; 9(7):e103840. PubMed ID: 25078269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR2, TLR3, TLR4, TLR9 and TLR11 expression on effector CD4
    Patidar A; Shukla D; Bodhale N; Saha B
    Exp Parasitol; 2023 Dec; 255():108645. PubMed ID: 37949424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects.
    Hodge S; Hodge G; Nairn J; Holmes M; Reynolds PN
    COPD; 2006 Dec; 3(4):179-87. PubMed ID: 17361498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2
    Sales MC; Kasahara TM; Sacramento PM; Rossi ÁD; Cafasso MOSD; Oyamada HAA; Hygino J; Alvim F; Andrade RM; Cristina Vasconcelos C; Bento CAM
    Immunology; 2021 Mar; 162(3):290-305. PubMed ID: 33112414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants.
    Pomerenke A; Lea SR; Herrick S; Lindsay MA; Singh D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2409-2417. PubMed ID: 27729782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD.
    Paats MS; Bergen IM; Hoogsteden HC; van der Eerden MM; Hendriks RW
    Eur Respir J; 2012 Aug; 40(2):330-7. PubMed ID: 22183488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte toll-like receptor expression in pathergy positive and negative Behçet's disease patients.
    van der Houwen TB; Dik WA; Goeijenbier M; Hayat M; Nagtzaam NMA; van Hagen M; van Laar JAM
    Rheumatology (Oxford); 2020 Dec; 59(12):3971-3979. PubMed ID: 32756992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.